Market Overview

Benzinga's Top Pre-Market Gainers

Related LRN
Lost Money On K12 Shares In Late 2013? Wait Until You See What Management Kept From You...It's Not Pretty
K12 Inc. is Expanding in Midst of Headwinds and Changing Dynamics
Related VICL
US Stock Futures Edge Higher Ahead Of Retail Sales, Jobless Claims Data
Vical Completes Enrollment In Its Therapeutic HSV-2 Vaccine Clinical Trial

K12 (NYSE: LRN) soared 13.66% to $24.30 in the pre-market trading. K12 reported a better-than-expected fourth-quarter profit.

Vical (NASDAQ: VICL) surged 9.28% to $4.12 in the pre-market session. Vical announced today a worldwide, nonexclusive license to Bristol-Myers Squibb Company (NYSE: BMY).

Cliffs Natural Resources (NYSE: CLF) added 2.41% to $41.60 in the pre-market session. Cliffs Natural Resources' PEG ratio is 1.09.

Arena Pharmaceuticals (NASDAQ: ARNA) moved up 1.79% to $8.51 in the pre-market session. Arena Pharmaceuticals shares have surged 464.87% over the past 52 weeks, while the S&P 500 index has gained 20.85% in the same period.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (ARNA + BMY)

Around the Web, We're Loving...

Get Benzinga's Newsletters